Abstract

Right at the end of 2019, the world saw an outbreak of a new type of SARS (severe acute respiratory syndrome) disease, SARS-Cov-2, or COVID-19. Even in 2022, around 1 million people worldwide are getting infected with the virus every day. To date, more than 6 million people have died as a result of the virus. To tackle the pandemic, the first step is to successfully detect the virus among the mass population. The most popular method is the RT-PCR test, which, unfortunately, is not always conclusive. The physicians thus suggest lung CT tests for the patients for clinical relevance. But the problem with lung CT scans for the detection of coronavirus is that the COVID-19 infected scan is very similar to community-affected pneumonia (CAP) infected scan, and the results in many cases get wrongly interpreted. In addition, the virus is always mutating into different strains, and the severity and infection pattern slightly change with each mutation. Because of this rapid mutation, a large and balanced dataset of lung CT scans is not always available. In this work, we systematically evaluate the accuracy of a deep 3D convolutional neural network (CNN) on a small-scale and highly imbalanced dataset of lung CT scans (the SPGC COVID 2021 dataset). Our experiments show that it can outperform previous state-of-the-art 3D CNN models with proper regularization, an appropriate number of dense layers, and a weighted loss function. Our research, therefore, suggests an effective solution for identifying COVID-19 in lung CT scans using deep learning for small and highly imbalanced datasets.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call